Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 26 February, 2021

BARCLAYS PLC

FROM 38.5(b) REPORT OSMOTICA BCI

FROM 38.5(b) REPORT OSMOTICA BCI

BARCLAYS PLC

 

Ap27

FORM 38.5(b)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

Name of exempt principal trader: BARCLAYS CAPITAL INC
Company dealt in OSMOTICA PHARMACEUTICALS PLC
Class of relevant security to which the  US$0.01 ordinary shares
dealings being disclosed relate 
Date of dealing

25 February 2021

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Class of relevant security: ORD    
  Interests Short Positions
 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

320

0.00%

0

0.00%

   

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

0

0.00%

0

0.00%

   

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

 

TOTAL:

320

0.00%

0

0.00%

 

 

 

 

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap28

3. DEALINGS (Note 3)

a. Purchases and sales

Purchase/sale

Number of

Price per unit

 

securities

 

Purchase

1

4.1900  USD

Purchase

4

4.1000  USD

Sale

1

4.1900  USD

Sale

4

4.1000  USD

b. Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit

(Note 4)

 

 

 

 

c. Options transactions in respect of existing relevant securities

i. Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

 

 

 

 

 

 

 

ii. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4)

 

 

 

d. Other dealings (including transactions in respect of new securities) (Note 3)

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

Ap29

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 38.5(b) attached?  NO
Date of disclosure:

26 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Name of offeree/offeror with which connected
Nature of connection  

 


a d v e r t i s e m e n t